Literature DB >> 35300369

Permeation characteristics of tetracyclines in parallel artificial membrane permeation assay II: Effect of divalent metal ions and mucin.

Sachika Yamauchi1, Daisuke Inoue1, Kiyohiko Sugano1.   

Abstract

The bioavailability of tetracyclines is markedly decreased when co-administered with antacids, milk, or food containing Ca2+. Previously, it was suggested that the effective intestinal permeation of tetracycline (TC) was decreased due to Ca2+ linked mucin binding in the mucosal side. In the present study, we investigated the effect of Ca2+, Mg2+, and mucin on the membrane permeation of six tetracyclines (TC, oxytetracycline (OTC), minocycline (MINO), doxycycline (DOXY), demeclocycline (DMCTC), and chlortetracycline (CTC)). The membrane permeability values (Pe) of tetracyclines were measured by the parallel artificial membrane permeation assay (PAMPA) using soybean lecithin - decane (SL-PAMPA) and octanol (OCT-PAMPA) membranes. In SL-PAMPA, Ca2+ markedly decreased the Pe values of all tetracyclines. In OCT-PAMPA, Ca2+ increased the Pe values of TC, CTC, and DMCTC, but not DOXY, OTC, and MINO. Mg2+ decreased the Pe values of all tetracyclines in both SL-PAMPA and OCT-PAMPA (except for CTC in OCT-PAMPA). The addition of mucin had little or no effect in all cases. In contrast to the previously suggested mechanism, the results of the present study suggested that Ca2+ chelate formation decreased the membrane permeation of tetracyclines, irrespective of Ca2+ linked mucin binding. Molecular speciation analysis suggested that the permeation of TC - metal chelates was negligibly small in SL-PAMPA.
Copyright © 2020 by the authors.

Entities:  

Keywords:  artificial membrane; cation; metal; mucin; permeability; phospholipid; tetracycline

Year:  2020        PMID: 35300369      PMCID: PMC8915580          DOI: 10.5599/admet.797

Source DB:  PubMed          Journal:  ADMET DMPK        ISSN: 1848-7718


  40 in total

1.  Lipophilicity Profiles of Ampholytes.

Authors:  Alessandra Pagliara; Pierre-Alain Carrupt; Giulia Caron; Patrick Gaillard; Bernard Testa
Journal:  Chem Rev       Date:  1997-12-18       Impact factor: 60.622

2.  METAL COMPLEXATION OF THE TETRACYCLINE HYDROCHLORIDES.

Authors:  J T DOLUISIO; A N MARTIN
Journal:  J Med Chem       Date:  1963-01       Impact factor: 7.446

3.  Stabilities of some alkaline earth chelates of tetracycline.

Authors:  D C MAXWELL; P J SMITH; S P WILFORD
Journal:  Nature       Date:  1963-05-11       Impact factor: 49.962

4.  Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging.

Authors:  C Schiller; C-P Fröhlich; T Giessmann; W Siegmund; H Mönnikes; N Hosten; W Weitschies
Journal:  Aliment Pharmacol Ther       Date:  2005-11-15       Impact factor: 8.171

5.  Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.

Authors:  Daphne D Williams; Bin Peng; Christine K Bailey; Mary B Wire; Yanli Deng; Jung Wook Park; David A Collins; Shiva G Kapsi; Julian M Jenkins
Journal:  Clin Ther       Date:  2009-04       Impact factor: 3.393

6.  The influence of coffee with milk and tea with milk on the bioavailability of tetracycline.

Authors:  H Jung; A A Peregrina; J M Rodriguez; R Moreno-Esparza
Journal:  Biopharm Drug Dispos       Date:  1997-07       Impact factor: 1.627

7.  High throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeation assay.

Authors:  K Sugano; H Hamada; M Machida; H Ushio
Journal:  J Biomol Screen       Date:  2001-06

8.  Equilibrium studies on tetracycline-metal ion systems.

Authors:  M Novák-Pékli; M el-Hadi Mesbah; G Pethó
Journal:  J Pharm Biomed Anal       Date:  1996-06       Impact factor: 3.935

9.  Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.

Authors:  Rajesh Krishna; Lilly East; Patrick Larson; Chandni Valiathan; Kristin Butterfield; Yang Teng; Martha Hernandez-Illas
Journal:  J Pharm Pharmacol       Date:  2016-09-27       Impact factor: 3.765

Review 10.  Absorption interactions with fluoroquinolones. 1995 update.

Authors:  B M Lomaestro; G R Bailie
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.